It’s heartbreaking, but all too common…
A patient calls their doctor after repeated seizures.
He had missed his medication for about a week. He had recently been laid off and lost insurance coverage.
He couldn’t afford to refill his eslicarbazepine acetate (Aptiom) prescription.
Getting the FDA to retract a decision, is like getting the toothpaste back in the tube, after it’s been squeezed out…
Whether it’s “yes” or “no,” there is no “maybe so”.
A good example is the new all star Alzheimer’s drug aducanumab.
Whether it’s “yes” or “no,” there is no “maybe so”.
In a special presentation from the Institute of Medicine (IOM), a groundbreaking report was released with 13 recommendations that the IOM designed to help improve care for all people with epilepsy…